John Catalano

Adj ClinAssProf

19982018
If you made any changes in Pure these will be visible here soon.

Research Output 1998 2018

Filter
Article
2017
48 Citations (Scopus)

Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone

Thieblemont, C., Tilly, H., Da Silva, M. G., Casasnovas, R. O., Fruchart, C., Morschhauser, F., Haioun, C., Lazarovici, J., Grosicka, A., Perrot, A., Trotman, J., Sebban, C., Caballero, D., Greil, R., Van Eygen, K., Cohen, A. M., Gonzalez, H., Bouabdallah, R., Oberic, L., Corront, B. & 10 others, Choufi, B., Lopez-Guillermo, A., Catalano, J., Van Hoof, A., Briere, J., Cabeçadas, J., Salles, G., Gaulard, P., Bosly, A. & Coiffier, B. B., 1 Aug 2017, In : Journal of Clinical Oncology. 35, 22, p. 2473-2481 9 p.

Research output: Contribution to journalArticleResearchpeer-review

62 Citations (Scopus)

Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial

Verstovsek, S., Mesa, R. A., Gotlib, J. R., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M. W. N., Miller, C. B., Silver, R. T., Talpaz, M., Winton, E. F., Harvey, J. H., Arcasoy, M. O., Hexner, E. O., Lyons, R. M., Paquette, R. L., Raza, A., Jones, M., Kornacki, D., Sun, K. & 1 others, Kantarjian, H. M., 22 Feb 2017, In : Journal of Hematology & Oncology. 10, 1, p. 1-14 14 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study

Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
2016

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases

Ratnasingam, S., Walker, P. A., Tran, H., Kaplan, Z. S., McFadyen, J., Tran, H., Teh, T-C., Fleming, S., Catalano, J. V., Chunilal, S. D., Johnston, A., Opat, S. S. & Shortt, J., 22 Nov 2016, In : Blood Advances. 1, 1, p. 31-35 5 p.

Research output: Contribution to journalArticleResearchpeer-review

2015
64 Citations (Scopus)

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Kipps, T. J., Eradat, H. A., Grosicki, S., Catalano, J., Cosolo, W., Dyagil, I. S., Yalamanchili, S., Chai, A., Sahasranaman, S., Punnoose, E. A., Hurst, D. & Pylypenko, H., 2015, In : Leukemia and Lymphoma. 56, 10, p. 2826 - 2833 8 p.

Research output: Contribution to journalArticleResearchpeer-review

135 Citations (Scopus)

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: Results of a median 3-year follow-up of COMFORT-I

Verstovsek, S., Mesa, R. A., Gotlib, J. R., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M. W. N., Miller, C. B., Silver, R. T., Talpaz, M., Winton, E. F., Harvey, J. H., Arcasoy, M. O., Hexner, E. O., Lyons, R. M., Raza, A., Vaddi, K., Sun, W., Peng, W. & 3 others, Sandor, V. A., Kantarjian, H. M. & COMFORT-I investigators, 2015, In : Haematologica: the hematology journal. 100, 4, p. 479-488 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
5 Citations (Scopus)

The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit

Harrison, S. J. A., Quach, H., Link, E. K., Feng, H., Dean, J., Copeman, M. B., van de Velde, H., Schwarer, A., Baker, B., Spencer, A., Catalano, J., Campbell, P., Augustson, B. M., Romeril, K. & Prince, H. M., 2015, In : American Journal of Hematology. 90, 5, p. 86 - 91 6 p.

Research output: Contribution to journalArticleOther

2014
10 Citations (Scopus)

A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)

Tran, H. A., Brighton, T., Grigg, A. P., McRae, S., Dixon, J., Thurley, D., Gandhi, M. K., Truman, M., Marlton, P. & Catalano, J., 2014, In : British Journal of Haematology. 167, 2, p. 243 - 251 9 p.

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia

Awan, F. T., Hillmen, P., Hellmann, A., Robak, T., Hughes, S. G., Trone, D., Shannon, M., Flinn, I. W., Byrd, J. C. & LUCID trial investigators, 1 Nov 2014, In : British Journal of Haematology. 167, 4, p. 466-477 12 p.

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Mesa, R. A., Kiladjian, J. J., Verstovsek, S., Al-Ali, H. K., Gotlib, J. R., Gisslinger, H., Levy, R. S., Siulnik, A., Gupta, V., Khan, M., DiPersio, J. F., McQuitty, M., Catalano, J., Hunter, D. S., Knoops, L., Deininger, M. W. N., Cervantes, F., Miller, C. B., Vannucchi, A. M., Silver, R. T. & 15 others, Barbui, T., Talpaz, M., Barosi, G., Winton, E. F., Mendeson, E., Harvey, J. H., Arcasoy, M. O., Hexner, E. O., Lyons, R. M., Paquette, R. L., Raza, A., Sun, W., Sandor, V. A., Kantarjian, H. M. & Harrison, C. N., 1 Feb 2014, In : Haematologica: the hematology journal. 99, 2, p. 292 - 298 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
384 Citations (Scopus)

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. R., Cavo, M. M., Pinto, A. I., Weisel, K. C., Ludwig, H., Bahlis, N. J., Banos, A., Tiab, M., Delforge, M., Cavenagh, J. D., Geraldes, C., Lee, J., Chen, C., Oriol, A., De La Rubia, J., Qiu, L. & 14 others, White, D. J., Binder, D., Anderson, K. C., Fermand, J. P., Moreau, P., Attal, M., Knight, R. D., Chen, G., Van Oostendorp, J., Jacques, C., Ervin-Haynes, A. L., Avet-Loiseau, H., Hulin, C. & Facon, T., 2014, In : New England Journal of Medicine. 371, 10, p. 906 - 917 12 p.

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia

Weisser, M., Yeh, R. F., Duchateau-Nguyen, G., Palermo, G., Nguyen, T. Q., Shi, X., Stinson, S. Y., Yu, N., Dufour, A., Robak, T., Salogub, G. N., Dmoszynska, A., Solal-Celigny, P., Warzocha, K., Loscertales, J., Catalano, J., Larratt, L., Rossiev, V. A., Bence-Bruckler, I., Geisler, C. H. & 12 others, Montillo, M., Fischer, K., Fink, A. M., Hallek, M., Bloehdorn, J., Busch, R., Benner, A., Doḧner, H., Valente, N., Wenger, M. K., Stilgenbauer, S. & Dornan, D., 17 Jul 2014, In : Blood. 124, 3, p. 420-425 6 p.

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

Seymour, J. F., Pfreundschuh, M. M., Trneny, M., Sehn, L., Catalano, J., Csinady, E., Moore, N. & Coiffier, B. B., 2014, In : Haematologica: the hematology journal. 99, 8, p. 1343 - 1349 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
2013
110 Citations (Scopus)

Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial

Mesa, R. A., Gotlib, J., Gupta, V., Catalano, J., Deininger, M., Shields, A., Miller, C., Silver, R., Talpaz, M., Winton, E. F., Harvey, J. H., Hare, T., Erickson-Viitanen, S., Sun, W., Sandor, V., Levy, R. S., Kantarjian, H. M. & Verstovsek, S., 2013, In : Journal of Clinical Oncology. 31, 10, p. 1285 - 1292 8 p.

Research output: Contribution to journalArticleResearchpeer-review

115 Citations (Scopus)

Efficacy, safety and survival with ruxolitinib in patients with smyelofibrosis: results of a median 2-year follow-up of COMFORT-I

Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J., Deininger, M., Miller, C., Silver, R., Talpaz, M., Winton, E. F., Harvey, J. H., Arcasoy, M. O., Hexner, E., Lyons, R. M., Paquette, R., Raza, A., Vaddi, K., Erickson-Viitanen, S. & 3 others, Sun, W., Sandor, V. & Kantarjian, H. M., 2013, In : Haematologica: the hematology journal. 98, 12, p. 1865 - 1871 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
30 Citations (Scopus)

Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients

Dufour, A., Palermo, G., Zellmeier, E., Mellert, G., Duchateau-Nguyen, G., Schneider, S., Benthaus, T., Kakadia, P. M., Spiekermann, K., Hiddemann, W., Braess, J., Truong, S., Patten, N., Wu, C-L., Lohmann, S., Dornan, D., GuhaThakurta, D., Yeh, R. F., Salogub, G., Solal-Celigny, P. & 7 others, Dmoszynska, A., Robak, T., Montillo, M., Catalano, J., Geisler, C. H., Weisser, M. & Bohlander, S. K., 2 May 2013, In : Blood. 121, 18, p. 3650-3657 8 p.

Research output: Contribution to journalArticleResearchpeer-review

56 Citations (Scopus)

The clinical benefit of ruxolitinib across patient subgroups: Analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

Verstovsek, S., Mesa, R. A., Gotlib, J. R., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M. W. N., Miller, C. B., Silver, R. T., Talpaz, M., Winton, E. F., Harvey, J. H., Arcasoy, M. O., Hexner, E. O., Lyons, R. M., Paquette, R. L., Raza, A., Vaddi, K., Erickson-Viitanen, S. & 3 others, Sun, W., Sandor, V. A. & Kantarjian, H. M., May 2013, In : British Journal of Haematology. 161, 4, p. 508-516 9 p.

Research output: Contribution to journalArticleResearchpeer-review

2012
1001 Citations (Scopus)

A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis

Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J., Deininger, M., Miller, C., Silver, R., Talpaz, M., Winton, E. F., Harvey, J. H., Arcasoy, M. O., Hexner, E., Lyons, R. M., Paquette, R., Raza, A., Vaddi, K., Erickson-Vittanen, S. & 4 others, Koumenis, I. L., Sun, W., Sandor, V. & Kantarjian, H. M., 2012, In : New England Journal of Medicine. 366, 9, p. 799 - 807 9 p.

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms

Ghesquières, H., Cartron, G., Seymour, J. F., Delfau-Larue, M. H., Offner, F., Soubeyran, P., Perrot, A., Brice, P., Bouabdallah, R., Sonet, A., Dupuis, J., Casasnovas, R. O., Catalano, J. V., Delmer, A., Jardin, F., Verney, A., Dartigues, P. & Salles, G., 27 Sep 2012, In : Blood. 120, 13, p. 2650-2657 8 p.

Research output: Contribution to journalArticleResearchpeer-review

506 Citations (Scopus)

Continuous lenalidomide treatment for newly diagnosed multiple myeloma

Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jedrzejczak, W., Zodelava, M., Weisel, K. C., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Blade, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C. & 7 others, Yehuda, D. B., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C. & Dimopoulos, M. A., 2012, In : New England Journal of Medicine. 366, 19, p. 1759 - 1769 11 p.

Research output: Contribution to journalArticleResearchpeer-review

35 Citations (Scopus)

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

Iland, H., Bradstock, K., Seymour, J., Hertzberg, M., Grigg, A. P., Taylor, K., Catalano, J., Cannell, P., Horvath, N., Deveridge, S., Browett, P. J., Brighton, T., Chong, S. L., Springall, F., Ayling, J., Catalano, A., Supple, S. G., Collins, M., Di Iulio, J. & Reynolds, J., 1 Feb 2012, In : Haematologica: the hematology journal. 97, 2, p. 227-234 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
12 Citations (Scopus)

The KIR2DS2/DL2 genotype is associated with adult persistent/chronic and relapsed immune thrombocytopenia independently of FCGR3a-158 polymorphisms

Nourse, J. P., Lea, R., Crooks, P., Wright, G., Tran, H. A., Catalano, J., Brighton, T., Grigg, A. P., Marlton, P. & Gandhi, M. K., 2012, In : Blood Coagulation and Fibrinolysis. 23, 1, p. 45 - 50 6 p.

Research output: Contribution to journalArticleResearchpeer-review

2011
1 Citation (Scopus)

Risk and response adapted therapy for early stage Hodgkin lymphoma: A prospective multicenter study of the Australasian Leukaemia and lymphoma group/trans-tasman radiation oncology group

Wirth, A., Grigg, A., Wolf, M., Goldstein, D., Johnson, C., Davis, S., Dutu, G., Kypreos, P., Smith, C., Kneebone, A., Herzberg, M., Joseph, D., Catalano, J., Roos, D., Stone, J. & Reynolds, J., May 2011, In : Leukemia and Lymphoma. 52, 5, p. 786-795 10 p.

Research output: Contribution to journalArticleResearchpeer-review

676 Citations (Scopus)

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomised controlled trial

Salles, G., Seymour, J. F., Offner, F., López-Guillermo, A., Belada, D., Xerri, L., Feugier, P., Bouabdallah, R., Catalano, J. V., Brice, P., Caballero, D., Haioun, C., Pedersen, L. M., Delmer, A., Simpson, D., Leppa, S., Soubeyran, P., Hagenbeek, A., Casasnovas, R. O., Intragumtornchai, T. & 10 others, Fermé, C., Da Silva, M. G., Sebban, C., Lister, A., Estell, J. A., Milone, G., Sonet, A., Mendila, M., Coiffier, B. B. & Tilly, H., 1 Jan 2011, In : The Lancet. 377, 9759, p. 42-51 10 p.

Research output: Contribution to journalArticleResearchpeer-review

2010
1268 Citations (Scopus)

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial

Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A. M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G. D., Von Grünhagen, U., Bergmann, M., Catalano, J., Zinzani, P. L., Caligaris-Cappio, F., Seymour, J. F., Berrebi, A., Jäger, U., Cazin, B., Trneny, M., Westermann, A. & 12 others, Wendtner, C. M., Eichhorst, B. F., Staib, P., Bühler, A., Winkler, D., Zenz, T., Böttcher, S., Ritgen, M., Mendila, M., Kneba, M., Döhner, H. & Stilgenbauer, S., 2 Oct 2010, In : The Lancet. 376, 9747, p. 1164-1174 11 p.

Research output: Contribution to journalArticleResearchpeer-review

44 Citations (Scopus)

Effect of FCGR2A and FCGR3A variants on CLL outcome

Dornan, D., Spleiss, O., Yeh, R. F., Duchateau-Nguyen, G., Dufour, A., Zhi, J., Robak, T., Moiseev, S. I., Dmoszynska, A., Solal-Celigny, P., Warzocha, K., Loscertales, J., Catalano, J., Afanasiev, B. V., Larratt, L., Rossiev, V. A., Bence-Bruckler, I., Geisler, C. H., Montillo, M., Wenger, M. K. & 1 others, Weisser, M., 18 Nov 2010, In : Blood. 116, 20, p. 4212-4222 11 p.

Research output: Contribution to journalArticleResearchpeer-review

371 Citations (Scopus)

Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia

Robak, T., Dmoszynska, A., Solal-Céligny, P., Warzocha, K., Loscertales, J., Catalano, J., Afanasiev, B. V., Larratt, L., Geisler, C. H., Montillo, M., Zyuzgin, I. S., Ganly, P. S., Dartigeas, C., Rosta, A., Maurer, J., Mendila, M., Saville, M. W., Valente, N., Wenger, M. K. & Moiseev, S. I., 1 Apr 2010, In : Journal of Clinical Oncology. 28, 10, p. 1756-1765 10 p.

Research output: Contribution to journalArticleResearchpeer-review

2008
131 Citations (Scopus)

Impact of early dose intensity on cytogenetic and molecular responses in chronicphase CMLpatients receiving 600 mg/day of imatinib as initial therapy

Hughes, T. P., Branford, S., White, D. L., Reynolds, J., Koelmeyer, R., Seymour, J. F., Taylor, K., Arthur, C., Schwarer, A., Morton, J., Cooney, J., Leahy, M. F., Rowlings, P., Catalano, J., Hertzberg, M., Filshie, R., Mills, A. K., Fay, K., Durrant, S., Januszewicz, H. & 5 others, Joske, D., Underhill, C., Dunkley, S., Lynch, K. & Grigg, A., 15 Nov 2008, In : Blood. 112, 10, p. 3965-3973 9 p.

Research output: Contribution to journalArticleResearchpeer-review

434 Citations (Scopus)

Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma

Marcus, R., Imrie, K., Solal-Celigny, P., Catalano, J., Dmoszynska, A., Raposo, J., Offner, F., Gomez-Codina, J., Belch, A. R., Cunningham, D., Wassner-Fritsch, E. & Stein, G., 2008, In : Journal of Clinical Oncology. 26, 28, p. 4579 - 4586 8 p.

Research output: Contribution to journalArticleResearchpeer-review

2005
798 Citations (Scopus)

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

Marcus, R., Imrie, K., Belch, A., Cunningham, D., Flores, E., Catalano, J., Solal-Celigny, P., Offner, F., Walewski, J., Raposo, J., Jack, A. & Smith, P., 2005, In : Blood. 105, 4, p. 1417 - 1423 7 p.

Research output: Contribution to journalArticleResearchpeer-review

1998
40 Citations (Scopus)

Dalteparin for deep venous thrombosis: a hospital-in-the home program

Ting, S. B. N., Ziegenbein, R. W., Gan, T. E., Catalano, J. V., Mongale, P., Silvers, J., Chambers, F. E., Ng, S. & McGrath, B. P., 1998, In : Medical Journal of Australia. p. 272 - 276 5 p.

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Haematological effects of betamethasone treatment in late pregnancy

Wallace, E. M., Ekkel, K., Cotter, T., Tippett, C. & Catalano, J. V., 1998, In : Australian and New Zealand Journal of Obstetrics and Gynaecology. p. 396 - 398 3 p.

Research output: Contribution to journalArticleResearchpeer-review